<code id='115A6E7548'></code><style id='115A6E7548'></style>
    • <acronym id='115A6E7548'></acronym>
      <center id='115A6E7548'><center id='115A6E7548'><tfoot id='115A6E7548'></tfoot></center><abbr id='115A6E7548'><dir id='115A6E7548'><tfoot id='115A6E7548'></tfoot><noframes id='115A6E7548'>

    • <optgroup id='115A6E7548'><strike id='115A6E7548'><sup id='115A6E7548'></sup></strike><code id='115A6E7548'></code></optgroup>
        1. <b id='115A6E7548'><label id='115A6E7548'><select id='115A6E7548'><dt id='115A6E7548'><span id='115A6E7548'></span></dt></select></label></b><u id='115A6E7548'></u>
          <i id='115A6E7548'><strike id='115A6E7548'><tt id='115A6E7548'><pre id='115A6E7548'></pre></tt></strike></i>

          
          WSS
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          fashion